Safety review: Nonsteroidal anti-inflammatory drugs (NSAIDs) and spontaneous abortion
Version 1.0, September 2016
A review has been carried out of the Product Information documents and package warnings for all non-steroidal anti-inflammatory drugs (NSAIDs) in relation to information provided about the potential increased risk of miscarriage due to exposure in early pregnancy. The evaluation included comparisons of Australian and international product information documents across the range of NSAIDs; a review of mandated warnings, published literature and therapeutic guidelines; and an analysis of case reports from the TGA Adverse Drug Reactions System database.
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open it from there.
- Safety review: Nonsteroidal anti-inflammatory drugs (NSAIDs) and spontaneous abortion (pdf,838kb)
- Safety review: Nonsteroidal anti-inflammatory drugs (NSAIDs) and spontaneous abortion (Word,536kb)
- Executive summary
- 1 Introduction
- 2 Background
- 3 The safety concern
- 4 Product Information and Labelling
- 5 Literature
- 6 Adverse Drug Reaction System (ADRS) data
- 7 Discussion